Sharps Technology, Inc. (NASDAQ:STSS) Short Interest Update

Sharps Technology, Inc. (NASDAQ:STSS) was the target of a significant increase in short interest in the month of April. As of April 15th, there was short interest totalling 352,700 shares, an increase of 52.9% from the March 31st total of 230,600 shares. Currently, 2.5% of the company’s shares are short sold. Based on an average daily trading volume, of 180,500 shares, the short-interest ratio is currently 2.0 days.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Sharps Technology stock. ORG Partners LLC bought a new stake in Sharps Technology, Inc. (NASDAQ:STSS) in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 100,046 shares of the company’s stock, valued at approximately $55,000. ORG Partners LLC owned 0.86% of Sharps Technology at the end of the most recent quarter. 17.17% of the stock is owned by institutional investors and hedge funds.

Sharps Technology Price Performance

Shares of STSS remained flat at $0.29 during midday trading on Friday. The stock had a trading volume of 14,955 shares, compared to its average volume of 77,862. Sharps Technology has a 1-year low of $0.27 and a 1-year high of $1.58. The stock’s 50-day moving average is $0.33 and its two-hundred day moving average is $0.38.

Sharps Technology (NASDAQ:STSS) last released its quarterly earnings results on Friday, March 29th. The company reported ($0.16) EPS for the quarter.

About Sharps Technology

Sharps Technology, Inc, a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. Sharps Technology, Inc was incorporated in 2017 and is based in Melville, New York.